首页> 外文期刊>Journal of Patient Safety & Quality Improvement >Prescription Audit towards Quality Indicators at a Tertiary Care Teaching Hospital in South India
【24h】

Prescription Audit towards Quality Indicators at a Tertiary Care Teaching Hospital in South India

机译:处方审计到印度南部的高等教育教学医院质量指标

获取原文
获取外文期刊封面目录资料

摘要

Introduction: The World Health Organization has laid down guidelines for rational prescriptions. Adherence to those guidelines is an important aspect of medication safety. In India, such adherence is mandatory towards National Accreditation Board for Hospitals and Health-care Providers (NABH) accreditation of health-care facilities. The audition of the prescriptions is therefore a quality improvement process that indirectly benefits the health-care stakeholders. Such an audit is part of the NABH Management of Medication and is monitored by the Pharmacy and Therapeutics (P&T) committee in most hospitals. Materials and Methods: This prospective study was conducted between December 2018 and November 2019. An audit was carried out using 4800 case sheets from different in-patient departments of Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, India. The data were recorded in a predefined audit form. Results: Out of 4800 prescriptions, 71% (n=3408) of the audited orders had drugs written down in the capital; moreover, 97% (n=4656) and 47% (n=2256) of the prescriptions were legible and were written in generics, respectively. Furthermore, 97% (n=4656) of the orders had a physician’s signature, and 70% (3360) of them had a clinical review. It should be noted that only 1% (n=48) of the orders had drug-drug and drug-food documented interactions. Conclusion: According to the results of this study, physicians did not document suggestions regarding drug-drug and drug-food interactions. Moreover, there were fewer numbers of prescriptions written in generics. In addition, the majority of the medication orders were legible and adhered to standards in the 12th month. This may be due to sharing the monthly audit reports with various departments and the continuous feedback process involving the P&T committee.
机译:介绍:世界卫生组织已奠定了理性处方的指导方针。遵守这些指导方针是药物安全的一个重要方面。在印度,这种遵守是国家认证委员会为医院和医疗保健提供者(NABH)的保健设施认证的强制性。因此,处方的试验是一种质量改进过程,间接享受医疗保健利益攸关方。这样的审计是纳米纳米管理的一部分药物,由药房和治疗方法(P&T)委员会监测大多数医院。材料和方法:这项前瞻性研究于2018年12月和2019年11月进行。使用印度孟加拉堡研究中心不同的患有4800家不同内部部门的4800个案例表进行了审计。数据以预定义的审计表格记录。结果:出于4800个处方,审计订单的71%(N = 3408)有毒品在首都汇编;此外,97%(n = 4656)和47%(n = 2256)的处方易易读,分别用泛型写入。此外,订单的97%(N = 4656)的命令具有医生的签名,70%(3360)人进行了临床审查。应该注意的是,订单中只有1%(n = 48)的毒品和药物食品有记录的相互作用。结论:根据本研究的结果,医生没有关于毒品 - 药物和毒品相互作用的建议。此外,在泛型中编写了较少数量的处方。此外,大多数药物订单易读并遵守第12个月的标准。这可能是由于与各部门分享每月审计报告以及涉及P&T委员会的持续反馈过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号